Audio Recap: COVID-19 at IDWeek 2022
Key COVID-19 Studies Influencing My Practice Following IDWeek 2022—Audio Recap

Released: November 18, 2022

Princy N Kumar
Princy N Kumar, MD, FIDSA, MACP

Activity

Progress
1
Course Completed

In this episode, Princy N. Kumar, MD, and Paul E. Sax, MD, discuss new COVID-19 data from IDWeek 2022, including:

  • COVID-19 vaccines, including omicron BA.1 bivalent booster
  • Risk factors for breakthrough COVID-19 infections
  • COVID-19 diagnostics, including digital droplet PCR
  • COVID-19 therapeutics, including:
    • Nirmatrelvir plus ritonavir
    • Tixagevimab plus cilgavimab
    • Baricitinib
    • Tocilizumab
    • Inhaled interferon β-1a
  • COVID-19 therapeutics and outcomes in patients with immunocompromise
  • Long COVID